ctrl K

MBX Biosciences Inc. Comm... (MBX)

NASDAQ: MBX · Real-Time Price · USD

12.04

0.76 (6.74%)

At close: May 02, 2025, 3:59 PM

12.00

-0.37%

After-hours: May 02, 2025, 04:05 PM EDT

MBX Biosciences Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	49.35M	30.52M	24.21M
Short-Term Investments	212.8M	50.15M	18.25M
Long-Term Investments	n/a	n/a	n/a
Other Long-Term Assets	50K	50K	42K
Receivables	682K	208K	142K
Inventory	n/a	n/a	n/a
Other Current Assets	803K	133K	84K
Total Current Assets	267.29M	83.47M	44.21M
Property-Plant & Equipment	1.2M	665K	842K
Goodwill & Intangibles	n/a	n/a	n/a
Total Long-Term Assets	1.25M	715K	884K
Total Assets	268.54M	84.18M	45.09M
Account Payables	5.33M	1.39M	976K
Deferred Revenue	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a
Other Current Liabilities	2.5M	1.36M	1.13M
Total Current Liabilities	11.05M	3.93M	3.43M
Long-Term Debt	n/a	n/a	n/a
Other Long-Term Liabilities	42K	152.55M	83.94M
Total Long-Term Liabilities	42K	152.72M	84.27M
Total Liabilities	11.09M	156.65M	87.7M
Total Debt	171K	324K	461K
Common Stock	5K	1K	1K
Retained Earnings	-137.5M	-75.58M	-43.02M
Comprehensive Income	55K	60K	3K
Shareholders Equity	257.44M	-72.47M	-42.6M
Total Investments	212.8M	50.15M	18.25M